Conference Program - ABRF 2011 - Association of Biomolecular ...

Recommendations

Info

Demos (as of January 29, 2011)Monday, February 21 — 12:00 pm – 12:15 pmExhibit Hall Demo StageMonday, February 21 — 12:30 pm – 12:45 pmExhibit Hall Demo StageExhibit Booth: 503DemosInnovations in protein massspectrometry from Protea Biosciences:New bioanalytical tools for proteinanalysis and characterizationSpeakers: Christopher A. Bolcato, Technical ServicesManager, and Haddon E. Goodman, Product MarketingManagerPresentation will include discussion around innovative technologiesand techniques in gel protein separation and recovery, highabundant protein depletion, and new surfactant technologydeveloped by Protea Biosciences. Several new products will bediscussed that aid in the preparation of protein samples for massspectrometry.Monday, February 21 — 12:15 pm – 12:30 pmExhibit Hall Demo StageExhibit Booth: 515Illumina’s Genotyping Portfolio Featuringa New FFPE SolutionThe revolutionary Infinium HD FFPE Restore kit has expandedIllumina’s broad portfolio of array solutions to enable genotypingof formalin-fixed, paraffin-embedded (FFPE) samples on theInfinium platform. Join us to hear more about this exciting optionavailable for the CyotSNP and OmniExpress arrays. We’ll alsodescribe the latest evolution of iSelect, the most flexible customgenotyping option available today, and give a brief update onthe Omni GWAS Roadmap.Comprehensive Genomic Tools fromClinical Research to TranslationalMedicine: Paving the Way forPersonalized MedicineSpeaker: Jessica Parra, Ph.D., Marketing Manager, GlobalField MarketingClinical researchers are making personalized medicine a realityby translating biomarker discoveries into clinical diagnostictests. Although many biomarker signatures have been identifiedin research labs, only a few microarray-based clinical diagnostictests have received clearance for commercialization. Clinical researchersface many challenges from the discovery process tovalidation and routine testing. Using a single platform from clinicalresearch discovery to clinical applications helps researchersto overcome the operational hurdles of commercialization. Affymetrixis paving the path to market with a toolkit that includesinstrumentation, arrays, and reagents for use in developing clinicaldiagnostic tests. The convenience of a cGMP-manufacturedkit helps to reduce rework and risk during the developmentprocess to fast-track commercializationMonday, February 21 — 1:00 pm – 1:15 pmExhibit Hall Demo StageExhibit Booth: 110NextGENe’s RNA-Seq Analysis toolSpeaker: Megan R. ManionNextGENe’s RNA-Seq Analysis tool, which includes a proprietaryalignment algorithm specifically designed for transcriptomedata, will be presented. Project set-up and results will be shown.Results, which include mutation detected, expression analysisand alternative splicing analysis, are displayed in the interactiveNextGENe Viewer which includes detailed annotation. Next-GENe is a standalone Windows-based program for the analysisof Next Generation Sequencing data and is compatible withdata from Illumina Genome Analyzers, Roche/454 GS FLX, FLXTitanium and Junior, the SOLiD System and Ion Torrent’s IonPersonal Genome Machine. In addition to RNA-Seq analysis,NextGENe can also be used for SNP/Indel detection, ChIP-Seq,miRNA analysis, de novo assembly, and metagenomic analyses.126 • ABRF 2011 — Technologies to Enable Personalized Medicine
Tuesday, February 22 — 12:00 pm – 12:15 pmExhibit Hall Demo StageExhibit Booth: 515My samples. My study. MiSeq TM .Introducing Illumina’s personalsequencing system.The MiSeq personal sequencing system delivers the fastest timeto answer, a revolutionary workflow, and the widest breadth ofsequencing applications, all in a compact and economical instrument.This session will provide an introduction to the instrumentand showcase the revolutionary workflow — come experience itfor yourself.DemosABRF 2011 — Technologies to Enable Personalized Medicine • 127
Page 7 and 8:
Meeting SponsorsThe Association of
Page 9 and 10:
Registration ServicesRegistration S
Page 12 and 13:
Presenter InformationPresenter Info
Page 14 and 15:
AwardsABRF Annual Award for Outstan
Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
Page 20 and 21:
Sunday, February 20 (Continued)(S1-
Page 22 and 23:
Sunday, February 20 (Continued)(W3-
Page 24 and 25:
Monday, February 21 (Continued)12:0
Page 26 and 27:
Tuesday, February 22 (Continued)9:0
Page 28 and 29:
Tuesday, February 22 (Continued)(W1
Page 30 and 31:
Satellite Educational Workshop Spon
Page 32 and 33:
SW2: An Introduction to Metabolomic
Page 34 and 35:
SW4: Lean Management in Core Facili
Page 36 and 37:
Plenary Session AbstractsPlenary Se
Page 38 and 39:
Scientific Session AbstractsScienti
Page 40 and 41:
Scientific SessionAbstractsstatisti
Page 42 and 43:
Scientific SessionAbstracts(S5) Hig
Page 44 and 45:
Scientific SessionAbstracts(S7-2) S
Page 46 and 47:
Workshop Session AbstractsWorkshop
Page 48 and 49:
Workshop SessionAbstractscase incor
Page 50 and 51:
Workshop SessionAbstracts(W7) Cellu
Page 52 and 53:
Workshop SessionAbstractsresolution
Page 54 and 55:
(W14-3) Galaxy Next Generation Sequ
Page 56 and 57:
Research Group Presentation Abstrac
Page 58 and 59:
Research GroupPresentation Abstract
Page 60 and 61:
Research GroupPresentation Abstract
Page 62 and 63:
Poster Session Abstracts**ABRF Post
Page 64 and 65:
Poster Abstractsglobal gene express
Page 66 and 67:
Poster Abstractsdiscussions of cont
Page 68 and 69:
Poster Abstractspossible applicatio
Page 70 and 71:
Poster Abstracts129 Bravo Automated
Page 73 and 74:
distribution. Additionally, we show
Page 75 and 76:
Illumina Genome Analyzer. PicoPlex
Page 77 and 78: uniformity, reproducibility of enri
Page 79 and 80: kits for Tempus TM and PAXgene® st
Page 81 and 82: 165 Benchmarking miRNA ExpressionLe
Page 83 and 84: Phoenix crystallography robot and a
Page 85 and 86: Laboratory is located next door and
Page 87 and 88: data of a Thermo Orbitrap instrumen
Page 89 and 90: **197 Multi-Functional Superparamag
Page 91 and 92: pattern of N-linked glycans in form
Page 93 and 94: advantage of using two separate 15
Page 95 and 96: allowed absolute quantitation. Comp
Page 97 and 98: levels between the animal groups. A
Page 99 and 100: MuDPIT, and off-gel electrophoresis
Page 101 and 102: 237 Multi-Site Assessment of Proteo
Page 103 and 104: with good limits of quantification
Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
Page 117 and 118: Roche Applied Science Booth 5009115
Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
Page 121 and 122: Exhibitor List in Booth OrderExhibi
Page 123 and 124: This workshop will present ways to
Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
Page 127: NotesNotesABRF 2011 — Technologie
Page 131 and 132: MARCH 16-20, 2012 • DISNEY’S CO
show all

Conference Program - ABRF 2011 - Association of Biomolecular ...

Create successful ePaper yourself

Delete template?

Save as template?